The very first Hyperbaric Veterinary Medicine chamber in the United Kingdom has been acquired by Fitzpatrick Referrals Orthopaedics and Neurology hospital in Eashing, Surrey.
Following some interesting results from the US, the team at Fitzpatrick Referrals will be evaluating the efficacy of hyperbaric oxygen therapy (HBOT) in tissue healing and reconstruction as well as several more novel treatments. In the human orthopaedic field, HBOT has been used to treat non-union fractures and osteoradionecrosis and to support the incorporation of bone grafts.
Founder and Managing Director of Fitzpatrick Referrals, Professor Noel Fitzpatrick, has spearheaded a number of world-class initiatives, said:
I have seen hyperbaric oxygen therapy produce encouraging results in America for a range of orthopaedic, neurologic and wound-associated conditions. At Fitzpatrick Referrals we are committed to providing optimal treatment options for each and every animal entrusted to our care. We have therefore welcomed hyperbaric oxygen therapy as an adjunct to our existing therapeutic modalities for specific indications. We are enthusiastic about the potential and look forward to sharing our outcome results in an evidence-based fashion as we move forward. Our core ethos is to provide all of the options for all of the animals all of the time, and the addition of HBOT as part of a customised care package for our patients adds an exciting new dimension
Update
Please note, that we are currently unable to provide a hyperbaric oxygen therapy service.
